![Page 1: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/1.jpg)
Pathogenesis and histopathological diagnosis of carcinoma of breast
Dr. Munazza Azam SindhuAssistant Professor Department of PathologyAziz Fatima Medical and Dental College
![Page 2: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/2.jpg)
![Page 3: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/3.jpg)
Carcinoma of breast
• Carcinoma of the breast is the most common non-skin malignancy in women and is second only to lung cancer as a cause of cancer deaths.
![Page 4: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/4.jpg)
ETIOLOGY AND PATHOGENESIS
![Page 5: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/5.jpg)
Sporadic
• The major risk factors for sporadic breast cancer are related to
• Hormone exposure• Gender
• Age at menarche and menopause
• Reproductive history• Breastfeeding• Exogenous estrogens.
![Page 6: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/6.jpg)
Familial Breast Cancer
– Approximately 12% of breast cancers occur due to inheritance of an identifiable susceptibility gene or genes.
– Inheritance of a defective copy of a tumor suppressor gene.
– BRCA1, BRCA2, TP53, and CHEK2
– Mutations in BRCA1 and BRCA2 are responsible for 80% to 90% of “single gene” familial breast cancers and about 3% of all breast cancers.
![Page 7: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/7.jpg)
• BRCA1-associated breast cancers:• Commonly poorly differentiated• ER-negative/HER2-negative (basal-like)
• BRCA2-associated breast carcinomas:• Relatively poorly differentiated• More often ER-positive than BRCA1 cancers.
Familial Breast Cancer
![Page 8: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/8.jpg)
Types of biopsy procedures
• Fine needle aspiration biopsy– ultrasound-guided
• Core needle biopsy– A slightly larger, hollow needle is used to withdraw
small cylinders (or cores) of tissue from the abnormal area in the breast.
• Surgical (open) biopsy– incisional biopsy
– removes only part of the suspicious area, enough to make a diagnosis.
– excisional biopsy– removes the entire tumor or abnormal area, with or without trying to
take out an edge of normal breast tissue
![Page 9: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/9.jpg)
MORPHOLOGY OF BREAST CARCINOMAS
![Page 10: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/10.jpg)
![Page 11: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/11.jpg)
![Page 12: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/12.jpg)
![Page 13: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/13.jpg)
DCIS
• Mastectomy is curative in greater than 95% of women
• Breast conservation is appropriate for most women but has a slightly higher risk of recurrence.
![Page 14: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/14.jpg)
Paget disease of breast
![Page 15: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/15.jpg)
Invasive (Infiltrating) Carcinoma
• Presents as a palpable mass.
• By the time becomes palpable, over half the patients will have axillary lymph node metastases.
• May be fixed to the chest wall or cause dimpling of the skin.
• Lymphatics may block the local area of skin drainage and cause lymphedema and thickening of the skin--- peau d'orange.
• Retraction of the nipple may develop
![Page 16: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/16.jpg)
Invasive ductal carcinoma
Divided according to 2 major criteria;
1. Cytoarchitectural variants--- 75% NOS type & others as special types.
2. Pattern of spread--- inflammatory carcinoma & Paget’s disease.
![Page 17: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/17.jpg)
Typical IDC, irregular crab like, white fibrous appearance,& chalky streaks, retraction of the overlying skin
![Page 18: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/18.jpg)
Invasive ductal carcinoma
Tumor can grow in diffuse sheets, nests, cords or as individual cells showing Glandular/tubular differentiation
![Page 19: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/19.jpg)
Medullary Carcinoma
Well circumscribed character & fleshy appearance
![Page 20: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/20.jpg)
Medullary Carcinoma
Large tumor cells grow in a syncytial fashion, & are sharply separated from the surrounding stroma, which is heavily infiltrated by lymphocytes & plasma cells
![Page 21: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/21.jpg)
Tubular Carcinoma
well differentiated with excellent prognosis
![Page 22: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/22.jpg)
Cribriform Carcinoma
• Tumour has cribriform appearance similar to its in situ counterpart but with stromal invasion
![Page 23: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/23.jpg)
Mucinous carcinoma
• Usually in post menopausal women.
• Grossly well circumscribed, crepitant to palpation
• Typical gelatinous gross appearance, sharply circumscribed quality
![Page 24: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/24.jpg)
Balls of cancer cells floating in gelatinous secretions
Mucinous carcinoma
![Page 25: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/25.jpg)
• Breast carcinoma with entire breast reddened & warm with widespread edema of skin simulation mastitis.
• Undifferentiated carcinoma with widespread carcinomatosis dermal lymphatics.
Inflammatory carcinoma
![Page 26: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/26.jpg)
Large tumour embolus in a dermal lymphatic in a case of clinical appearance of inflammatory carcinoma
Inflammatory carcinoma
![Page 27: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/27.jpg)
Invasive Lobular Carcinoma
• Palpable mass or mammographic density.
• A diffuse pattern of invasion without prominent desmoplasia--- a vaguely thickened area of the breast or subtle architectural changes on mammography.
• Greater incidence of bilaterality. • Incidence is increasing among postmenopausal
women, may be related to the use of postmenopausal hormone replacement therapy.
• Lack of accumulation of p-53, absence of E-cadherin.
![Page 28: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/28.jpg)
Invasive Lobular Carcinoma
Tumor cells small & uniform with round nuclei & grow in indian file pattern, Signet-ring cells are common.
![Page 29: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/29.jpg)
– Well-differentiated and moderately differentiated invasive lobular carcinomas
– Express hormone receptors, and are associated with LCIS in the majority of cases.
– HER2/neu over-expression is very rare.
– Poorly differentiated lobular carcinomas– Often lack hormone receptors, and may over-express
HER2/neu.
• If matched by grade and stage, lobular carcinomas have the same prognosis as carcinomas of NST.
Invasive Lobular Carcinoma
![Page 30: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/30.jpg)
Scarf bloom richardson grading
![Page 31: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/31.jpg)
Molecular Subtypes of Breast cancer
• Luminal Type A– ER+ &/or PR+, HER2-– Most common subtype– Hormone responsive– Good prognosis
• Luminal Type B– ER+ &/or PR+, HER2+– Worse outcome that Luminal A
• HER2+ (ER-)– Less common, aggressive
subtype– High grade histology– Outcome improved with
Herceptin– Risk at young age
• Basal-Like– Triple negative– Aggressive subtype– High grade histology– Risk at young age– More common in African
American women– Constitute 20% of all breast
cancers– Propensity for metastasis
![Page 32: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/32.jpg)
PROGNOSTIC & PREDICTIVE FACTORS
INVASIVE CARCINOMA VERSUS IN-SITU DISEASE
– Treated DCIS - majority are cured – Invasive carcinoma - 50 % have local or
distant metastasis at the time of diagnosis
SIZE OF PRIMARY TUMOUR– 1cm tumor, LN - 10 years survival rate >
90%– more than 2cm with LN – it is < 77 %– EXCEPR HER2 +VE CA
LYMPH NODE INVOLVEMENT AND NO. OF LYMPH NODES INVOLVED•Most important factor•10 years survival rate
– No nodal involvement 70 - 80 %– 1-3 positive nodes 35- 40 %– More than 10 positive nodes 10-15 %
DISTANT METASTASIS– Rarely curable– Palliations achieved only in ER +ve cases
LOCALLY ADVANCED DISEASE– Invading skin and skeletal muscle are
usually large, difficult to treat surgically
INFLAMMATORY CARCINOMA– ( less than 3 %)
– Poor prognosis, dermal lymphatic involvement
– 3 years survival rate - 3-10 %
![Page 33: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/33.jpg)
Clinical Stages
• Stage 0. DCIS or LCIS (5-year survival rate: 92%).
• Stage I. Invasive carcinoma 2 cm or less in diameter (including carcinoma in situ with microinvasion) without nodal involvement (or only metastases < 0.02 cm in diameter) (5-year survival rate: 87%).
• Stage II. Invasive carcinoma 5 cm or less in diameter with up to three involved axillary nodes or invasive carcinoma greater than 5 cm without nodal involvement (5-year survival rate: 75%).
![Page 34: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/34.jpg)
• Stage III. Invasive carcinoma 5 cm or less in diameter with four or more involved axillary nodes; invasive carcinoma greater than 5 cm in diameter with nodal involvement; invasive carcinoma with 10 or more involved axillary nodes; invasive carcinoma with involvement of the ipsilateral internal mammary lymph nodes; or invasive carcinoma with skin involvement, chest wall fixation, or clinical inflammatory carcinoma
(5-year survival rate: 46%).
• Stage IV. Any breast cancer with distant metastases (5-year survival rate: 13%).
Clinical Stages
![Page 35: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/35.jpg)
Recent Advances
There have been two recent advances in the breast cancer research field that have lead to paradigm shifts: first, the identification of intrinsic breast tumor subtypes, which has changed the way we think about breast cancer and second, the recent characterization of cancer stem cells (CSCs), which are suspected to be responsible for tumor initiation, recurrence and resistance to therapy. These findings have opened new exciting avenues to think about breast cancer therapeutic strategies.
![Page 36: Histopathological dignosis of carcinoma of breast](https://reader034.vdocuments.net/reader034/viewer/2022051301/58f1bd6a1a28ab8f618b456b/html5/thumbnails/36.jpg)